Aurora Cannabis Inc (ACB) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.030x

Based on the latest financial reports, Aurora Cannabis Inc (ACB) has a cash flow conversion efficiency ratio of 0.030x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$17.00 Million ≈ $12.30 Million USD) by net assets (CA$567.83 Million ≈ $410.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Aurora Cannabis Inc to measure how many days the company can operate on defensive assets alone.

Aurora Cannabis Inc - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Aurora Cannabis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Aurora Cannabis Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Aurora Cannabis Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Taokaenoi Food & Marketing Public Company Limited
BK:TKN
0.148x
Galectin Therapeutics Inc
NASDAQ:GALT
0.030x
Sanurhasta Mitra PT
JK:MINA
0.002x
Garuda Construction & Engineering
NSE:GARUDA
0.011x
Maeil Dairies Co. Ltd
KQ:267980
0.035x
Securitag Assembly Group Co Ltd
TWO:6417
0.023x
Atakey Patates Gida Sanayi ve Ticaret A.S.
IS:ATAKP
0.049x
I-MAB SPONS.ADS/1 -0001
F:0VY
-0.063x

Annual Cash Flow Conversion Efficiency for Aurora Cannabis Inc (2007–2025)

The table below shows the annual cash flow conversion efficiency of Aurora Cannabis Inc from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Aurora Cannabis Inc market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 CA$608.59 Million
≈ $440.25 Million
CA$16.00 Million
≈ $11.58 Million
0.026x +123.10%
2024-03-31 CA$601.87 Million
≈ $435.38 Million
CA$-68.51 Million
≈ $-49.56 Million
-0.114x +49.18%
2023-03-31 CA$517.14 Million
≈ $374.09 Million
CA$-115.82 Million
≈ $-83.78 Million
-0.224x -34.53%
2022-03-31 CA$662.35 Million
≈ $479.14 Million
CA$-110.27 Million
≈ $-79.77 Million
-0.166x -61.10%
2021-03-31 CA$2.04 Billion
≈ $1.47 Billion
CA$-210.58 Million
≈ $-152.33 Million
-0.103x +35.77%
2020-03-31 CA$2.13 Billion
≈ $1.54 Billion
CA$-342.14 Million
≈ $-247.50 Million
-0.161x -267.42%
2019-03-31 CA$4.39 Billion
≈ $3.18 Billion
CA$-192.25 Million
≈ $-139.07 Million
-0.044x +16.18%
2018-03-31 CA$1.56 Billion
≈ $1.13 Billion
CA$-81.67 Million
≈ $-59.08 Million
-0.052x +14.50%
2017-03-31 CA$218.93 Million
≈ $158.37 Million
CA$-13.38 Million
≈ $-9.68 Million
-0.061x +94.62%
2016-03-31 CA$5.96 Million
≈ $4.31 Million
CA$-6.77 Million
≈ $-4.90 Million
-1.136x -30.96%
2015-03-31 CA$3.83 Million
≈ $2.77 Million
CA$-3.32 Million
≈ $-2.40 Million
-0.867x -21.62%
2014-03-31 CA$1.35 Million
≈ $979.00K
CA$-965.11K
≈ $-698.14K
-0.713x -10.54%
2013-03-31 CA$694.20K
≈ $502.17K
CA$-447.84K
≈ $-323.96K
-0.645x -149.38%
2012-03-31 CA$1.07 Million
≈ $777.31K
CA$-277.98K
≈ $-201.09K
-0.259x -28.90%
2011-03-31 CA$1.37 Million
≈ $992.94K
CA$-275.48K
≈ $-199.28K
-0.201x -11055.39%
2010-03-31 CA$1.71 Million
≈ $1.24 Million
CA$-3.08K
≈ $-2.23K
-0.002x +92.54%
2009-03-31 CA$1.62 Million
≈ $1.17 Million
CA$-39.04K
≈ $-28.24K
-0.024x +53.43%
2008-03-31 CA$1.69 Million
≈ $1.22 Million
CA$-87.26K
≈ $-63.12K
-0.052x -247.38%
2007-03-31 CA$430.22K
≈ $311.22K
CA$15.11K
≈ $10.93K
0.035x --

About Aurora Cannabis Inc

TO:ACB Canada Drug Manufacturers - Specialty & Generic
Market Cap
$171.89 Million
CA$237.61 Million CAD
Market Cap Rank
#17257 Global
#548 in Canada
Share Price
CA$4.19
Change (1 day)
+0.96%
52-Week Range
CA$4.15 - CA$8.66
All Time High
CA$1808.40
About

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables … Read more